| Financial Year |
March 31 2023 |
| Monetary Funds |
662,072,397.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
58,180,331.46 |
| Accounts Receivable |
2,850,313,808.75 |
| Advances to Suppliers |
47,151,617.98 |
| Other Receivables |
83,638,148.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
527,767,006.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
139,449,470.70 |
| Other Current Assets |
38,501,200.57 |
| Total Current Assets |
8,801,283,176.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
5,164,469.61 |
| Fixed Assetes |
1,416,837,206.08 |
| Under-construction Projects |
2,757,191.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
168,484,861.47 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
518,846.94 |
| Deferred Income Tax Assets |
92,050,405.46 |
| Other Non-Current Assets |
207,018,853.55 |
| Sub-Total of Non-Current Assets |
2,054,207,101.93 |
| Total Assets |
10,855,490,278.29 |
| Short-Term Loans |
1,949,474,387.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,414,937,649.09 |
| Accounts Payable |
2,235,611,324.76 |
| Accounts Received In Advance |
36,608.30 |
| Employee Compensation Payable |
39,451,067.18 |
| Taxes Payable |
18,541,334.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
103,012,519.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
709,196,973.80 |
| Other Current Liabilities |
100,047,031.68 |
| Sub-Total of Current Liabilities |
6,777,176,635.93 |
| Long-term Loans |
703,914,441.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
41,666,666.68 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,215,237.10 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
880,679,565.88 |
| Total Liabilities |
7,657,856,201.81 |
| Paid-In Capital(Or Share Stock) |
435,268,478.00 |
| Capital Surplus |
1,744,449,966.22 |
| Surplus Reserve |
101,759,188.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
854,674,614.51 |
| Minority Stockholder's Interest |
58,044,807.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,139,589,268.62 |
| Owner's Equity（Stockholder's Equity） |
3,197,634,076.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,855,490,278.29 |
